Use access key #2 to skip to page content.
$3.51 0.25 (7.67%)
7/8/2008 4:00 PM

ACADIA Pharmaceuticals, Inc. (ACAD)

CAPS Rating:
**

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.

View All Commentary (ACAD)

Recs

0

Avatar Cosmo21 (< 20) Submitted: 4/01/08 6:42 PM : Outperform Start Price: $9.38 ACAD Score: -55.25

ACAD is a strong buy at this level! Partnership on the way and the stock price will be back on it.s way to 17.

Report this Post Replies: 0 | Reply

Featured Broker Partners